Sector: MedicalSciClone Pharmaceuticals, Inc. (NASDAQ: SCLN)
Ranking History
Scan Date: | 11/17/2009 |
Sector: | Medical |
Funamental : | 167 |
Technical : | 119 |
Performance : | 293 |
Overall: | 235 |
Number of Stocks: | 307 |
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 5 |
Technical : | 174 |
Performance : | 283 |
Overall: | 167 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 6 |
Technical : | 295 |
Performance : | 304 |
Overall: | 248 |
Number of Stocks: | 306 |
Headlines
- BioMed News Bytes: Transcept, ProUroCare, SciClone, ABIO
Nov 23, 2009 07:51 PM | ABIO, CRL, DRE, SCLN
- SciClone Announces Enrollment Completion in Phase 2 Oral Mucositis Trial of SCV-07
Nov 23, 2009 07:16 AM | SCLN
- SciClone Pharmaceuticals to Present at the Piper Jaffray Annual Healthcare Conference
Nov 23, 2009 07:00 AM | PJC, SCLN
- SciClone Pharmaceuticals Announces Presentations of SCV-07 Data at Upcoming Medical Meetings
Nov 12, 2009 04:30 PM | SCLN
- SciClone Reports Financial Results and Provides Commercial and Pipeline Updates for the Third Quarter of 2009
Nov 09, 2009 07:05 AM | SCLN
- SciClone Pharmaceuticals to Present at Two November Investor Conferences
Nov 03, 2009 07:01 AM | SCLN
- SciClone Announces Corporate Restructuring and Workforce Reduction
Oct 28, 2009 06:30 AM | SCLN
- SciClone Pharmaceuticals to Report Third Quarter 2009 Results on November 9
Oct 26, 2009 06:30 AM | SCLN
- SciClone Announces Enrollment of First Patient in Its Phase 2 Trial of SCV-07 in Hepatitis C
Oct 21, 2009 05:30 AM | SCLN
- RidgewaterEquity.com Free Fundamental Sector & Market Research on AWK, CVBF, SCLN, INSM, CPHD and SMOD
Oct 07, 2009 06:13 AM | CVBF, INSM, SCLN
- SciClone Reports Financial Results and Provides Pipeline Update for the Second Quarter of 2009
Aug 04, 2009 04:05 PM | SCLN
- SciClone Pharmaceuticals to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference
Jul 31, 2009 05:30 PM | SCLN
- SciClone Pharmaceuticals Announces Appointment of Jon S. Saxe as Chairman of Board of Directors
Jul 30, 2009 04:05 PM | SCLN
- SciClone Pharmaceuticals Expands Portfolio by Licensing Ondansetron RapidFilm(TM) for Chinese Market
Jul 27, 2009 04:05 PM | SCLN
- SciClone Pharmaceuticals to Report Second Quarter 2009 Results on August 4
Jul 22, 2009 04:17 PM | SCLN
- SciClone Pharmaceuticals, Inc. Added to Russell 3000(R) Index
Jun 30, 2009 06:00 AM | SCLN
- SciClone Pharmaceuticals, Inc. Files Shelf Registration Statement
May 20, 2009 04:05 PM | SCLN
- SciClone Reports Financial Results for the First Quarter of 2009
May 11, 2009 04:05 PM | SCLN
- SciClone Pharmaceuticals to Report First Quarter 2009 Results on May 11
Apr 29, 2009 05:30 PM | SCLN
- SciClone and Sigma Tau Reach Agreement to Resolve Director Election Contest for 2009 Annual Meeting of SciClone Stockholders
Mar 31, 2009 06:00 AM | SCLN
- Form 4 Jones Trevor M For: Jun 09 (10K)
Jun 11, 2009 07:17 PM
- Form 4 Lapointe Gregg Anthony For: Jun 09 (10K)
Jun 11, 2009 02:44 PM
- Form 4 SAXE JON S For: Jun 09 (10K)
Jun 11, 2009 01:34 PM
- Form 4 WOODMAN DEAN S For: Jun 09 (10K)
Jun 11, 2009 01:27 PM
- Form 4 Hawkins Richard J For: Jun 09 (10K)
Jun 11, 2009 01:16 PM
- Form 4 Lawrence Ira D For: Jun 09 (10K)
Jun 11, 2009 01:09 PM
- Form 4 SCHMID HANS P For: Jun 08 (10K)
Jun 08, 2009 08:01 PM
- Form 4 Blobel Friedhelm For: May 22 (10K)
May 26, 2009 01:45 PM
- Form 4 BAXTER JOHN D For: May 21 (10K)
May 22, 2009 04:46 PM
- Form 3 Rios Israel For: May 19 (10K)
May 19, 2009 02:30 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
SCLN
|
Compare to S&P
|
| YTD |
259.46 %
|
197.50 %
|
| 4 Weeks |
-5.67 %
|
-6.69 %
|
| 12 Weeks |
-41.92 %
|
-45.24 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -75.00 %
|
|
EPS Growth in Last Year: 100.00 %
|
|
Sales Growth in Last Quarter: -21.53 %
|
|
Sales Growth in Last Quarter: 20.32 %
|
|
